Skip to content

Terms of Use

Content is informational. Affiliate links may earn commission. Tirzepatide Peptide is not affiliated with any vendor unless explicitly stated.

Reviewed by the Tirzepatide Peptide Research Team · Last updated May 2026

References & Scientific Sources

  1. Ludvik B, et al. Tirzepatide versus insulin degludec (SURPASS-3). Lancet. 2021.
  2. Del Prato S, et al. Tirzepatide versus insulin glargine (SURPASS-4). Lancet. 2021.
  3. Coskun T, et al. Tirzepatide, a dual GIP/GLP-1 receptor agonist: mechanism. Mol Metab. 2018.

Sources are provided for educational reference. This content is informational and not a substitute for professional medical advice.